Avacta Group (LON:AVCT) Share Price Crosses Below Two Hundred Day Moving Average – What’s Next?

Avacta Group Plc (LON:AVCT) shares passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of GBX 71.65 and traded as low as GBX 62.58. Avacta Group shares last traded at GBX 63.30, with a volume of 1,239,356 shares changing hands.

Avacta Group Stock Performance

The stock’s 50-day moving average is GBX 69.32 and its 200-day moving average is GBX 71.62. The stock has a market cap of £306.16 million, a price-to-earnings ratio of -7.25 and a beta of 1.12. The company has a debt-to-equity ratio of 526.98, a current ratio of 0.95 and a quick ratio of 4.96.

Avacta Group (LON:AVCT) last released its earnings results on Wednesday, September 30th. The biotechnology company reported GBX (4.23) EPS for the quarter. Avacta Group had a negative return on equity of 1,293.07% and a negative net margin of 35,730.97%. Analysts anticipate that Avacta Group Plc will post -9.90 EPS for the current fiscal year.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).